Controlled drug delivery for glaucoma therapy using montmorillonite/Eudragit microspheres as an ion-exchange carrier

References

• QuigleyHANumber of people with glaucoma worldwideBr J Ophthalmol19968053893938695555
   PubMed Web of Science ®Google Scholar
• NatarajanJVAngMDarwitanAChattopadhyaySWongTTVenkatramanSSNanomedicine for glaucoma: liposomes provide sustained release of latanoprost in the eyeInt J Nanomedicine2012712313122275828
   PubMed Web of Science ®Google Scholar
• CarvalhoIMMarquesCSOliveiraRSCoelhoPBCostaPCFerreiraDCSustained drug release by contact lenses for glaucoma treatment – a reviewJ Control Release2015202768225617723
   PubMed Web of Science ®Google Scholar
• DaiYZhouRLiuLLuYQiJWuWLiposomes containing bile salts as novel ocular delivery systems for tacrolimus (FK506): in vitro characterization and improved corneal permeationInt J Nanomedicine201381921193323690687
   PubMed Web of Science ®Google Scholar
• LiXZhangZLiJSunSWengYChenHDiclofenac/biodegradable polymer micelles for ocular applicationsNanoscale20124154667467322732776
   PubMed Web of Science ®Google Scholar
• ZimmerAKreuterJMicrospheres and nanoparticles used in ocular delivery systemsAdv Drug Deliv Rev19951616173
   Web of Science ®Google Scholar
• KaurIPGargASinglaAKAggarwalDVesicular systems in ocular drug delivery: an overviewInt J Pharm2004269111414698571
   PubMed Web of Science ®Google Scholar
• AlmeidaAJSoutoESolid lipid nanoparticles as a drug delivery system for peptides and proteinsAdv Drug Deliv Rev200759647849017543416
   PubMed Web of Science ®Google Scholar
• GuanQChenWHuXDevelopment of lovastatin-loaded poly(lactic acid) microspheres for sustained oral delivery: in vitro and ex vivo evaluationDrug Des Devel Ther20159791798
   PubMed Web of Science ®Google Scholar
• HePLiuHTangZPoly(ester amide) blend microspheres for oral insulin deliveryInt J Pharm20134551–225926623876502
   PubMedGoogle Scholar
• OkamotoTUemotoSTabataYPrevention of trinitrobenzene sulfonic acid-induced experimental colitis by oral administration of a poly(lactic-coglycolic acid) microsphere containing prostaglandin E(2) receptor subtype 4 agonistJ Pharmacol Exp Ther2012341234034922300734
   PubMed Web of Science ®Google Scholar
• GaviniERassuGHaukvikTLanniCRacchiMGiunchediPMucoadhesive microspheres for nasal administration of cyclodextrinsJ Drug Target200917216817918985506
   PubMed Web of Science ®Google Scholar
• HuhYChoHJYoonISPreparation and evaluation of spray-dried hyaluronic acid microspheres for intranasal delivery of fexofenadine hydrochlorideEur J Pharm Sci201040191520149868
   PubMed Web of Science ®Google Scholar
• Andres-GuerreroVZongMRamsayENovel biodegradable polyesteramide microspheres for controlled drug delivery in ophthalmologyJ Control Release201521110511726003040
   PubMed Web of Science ®Google Scholar
• AllisonSDAnalysis of initial burst in PLGA microparticlesExpert Opin Drug Deliv20085661562818532918
   PubMed Web of Science ®Google Scholar
• NilkumhangSBasitAWThe robustness and flexibility of an emulsion solvent evaporation method to prepare pH-responsive microparticlesInt J Pharm20093771–213514119515519
   PubMedGoogle Scholar
• YeoYParkKControl of encapsulation efficiency and initial burst in polymeric microparticle systemsArch Pharm Res200427111214969330
   PubMed Web of Science ®Google Scholar
• ZhangWLiXYeTNanostructured lipid carrier surface modified with Eudragit RS 100 and its potential ophthalmic functionsInt J Nanomedicine201494305431525246787
   PubMed Web of Science ®Google Scholar
• PignatelloaRBucolobCSpedalieriaGMaltesebAPuglisiaGEudragit RS100® nanosuspensions for the ophthalmic controlled delivery of ibuprofenEur J Pharm Sci2002161–2536112113891
   PubMed Web of Science ®Google Scholar
• PignatelloaRBucolobCSpedalieriaGMaltesebAPuglisiaGFlurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic applicationBiomaterials200223153247325512102196
   PubMed Web of Science ®Google Scholar
• EnnajihHBouhfidREssassiEMBousminaMEl KadibAChitosan–montmorillonite bio-based aerogel hybrid microspheresMicroporous Mesoporous Mater2012152208213
   Web of Science ®Google Scholar
• dos SantosBRBacalhauFBPereira TdosSSouzaCFFaezRChitosan-montmorillonite microspheres: a sustainable fertilizer delivery systemCarbohydr Polym201512734034625965492
   PubMed Web of Science ®Google Scholar
• HouDGuiRHuSHuangYFengZPingQPreparation and characterization of novel drug-inserted-montmorillonite chitosan carriers for ocular drug deliveryAdv Nanoparticles2015437084
   Google Scholar
• HouDHuSHuangYPreparation and in vitro study of lipid nanoparticles encapsulating drug loaded montmorillonite for ocular deliveryAppl Clay Sci20161192277283
   Google Scholar
• HuangYTaoQHouDA novel ion exchange carrier based upon liposome-incorporated montmorillonite for ophthalmic delivery of betaxolol hydrochlorideInt J Nanomedicine20171211528031709
   PubMed Web of Science ®Google Scholar
• ZhengJPLuanLWangHYXiLFYaoKDStudy on ibuprofen/montmorillonite intercalation composites as drug release systemAppl Clay Sci2007364297301
   Web of Science ®Google Scholar
• AnirudhanTSSandeepSSynthesis and characterization of a novel pH-controllable composite hydrogel for anticancer drug deliveryNew J Chem201135122869
   Web of Science ®Google Scholar
• ShameliKBin AhmadMZargarMSynthesis and characterization of silver/montmorillonite/chitosan bionanocomposites by chemical reduction method and their antibacterial activityInt J Nanomedicine2011627128421499424
   PubMed Web of Science ®Google Scholar
• KevadiyaBDJoshiGVBajajHCLayered bionanocomposites as carrier for procainamideInt J Pharm20103881–228028620074630
   PubMedGoogle Scholar
• JelvehgariMBararJValizadehHShadrouSNokhodchiAFormulation, characterization and in vitro evaluation of theophylline-loaded Eudragit RS 100 microspheres prepared by an emulsion-solvent diffusion/evaporation techniquePharm Dev Technol201116663764420722498
   PubMed Web of Science ®Google Scholar
• CasolaroMCasolaroILamponiSStimuli-responsive hydrogels for controlled pilocarpine ocular deliveryEur J Pharm Biopharm201280355356122138000
   PubMed Web of Science ®Google Scholar
• VinardellMPGarciaLThe quantitive chlorioallantoic membrance test using trypan blue stain to predict the eye irritancy of liquid scintillation cocktailsToxicol In Vitro200014655155511033067
   PubMed Web of Science ®Google Scholar
• NascimentoDFSilvaACMansurCRCharacterization and evaluation of poly(ε-caprolactone) nanoparticles containing 2-ethylhexyl-p-methoxycinnamate, octocrylene, and benzophenone-3 in anti-solar preparationsJ Nanosci Nanotechnol20121297155716623035447
   PubMed Web of Science ®Google Scholar
• NguyenDHBeuermanRWWeverBDRosdyMThree-dimensional construct of the human corneal epithelium for in vitro toxicologySalemHKatzSAAlternative Toxicological MethodsBoca RatoCRC Press2003147159
   Google Scholar
• YorkMSteilingWA critical review of the assessment of eye irritation potential using the Draize rabbit eye testJ Appl Toxicol19981842332409719422
   PubMed Web of Science ®Google Scholar
• MoosaRMChoonaraYEdu ToitLCIn vivo evaluation and in-depth pharmaceutical characterization of a rapidly dissolving solid ocular matrix for the topical delivery of timolol maleate in the rabbit eye modelInt J Pharm20144661–229630624607446
   PubMedGoogle Scholar
• MorrisonJCMooreCGDeppmeierLMHGoldBGMeshulCKJohnsonECA rat model of chronic pressure-induced optic nerve damageExp Eye Res199764185969093024
   PubMed Web of Science ®Google Scholar
• Zaghouane-BoudiafHBoutahalaMKinetic analysis of 2,4,5-trichlorophenol adsorption onto acid-activated montmorillonite from aqueous solutionInt J Miner Process20111003–47278
   Google Scholar
• MomohMAKenechukwuFCAdedokunMOOdoCEAttamaAAPharmacodynamics of diclofenac from novel Eudragit entrapped microspheresDrug Deliv201421319320324171400
   PubMed Web of Science ®Google Scholar
• MundargiRCRangaswamyVAminabhaviTMpH-Sensitive oral insulin delivery systems using Eudragit microspheresDrug Dev Ind Pharm201137897798521417605
   PubMed Web of Science ®Google Scholar
• HaznedarSDortunçBPreparation and in vitro evaluation of Eudragit microspheres containing acetazolamideInt J Pharm2004269113114014698584
   PubMed Web of Science ®Google Scholar
• DongYFengSSPoly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugsBiomaterials200526306068607615894372
   PubMed Web of Science ®Google Scholar
• MendiorozSPajaresJABenitoIPesqueraCGonzalezFBlancoCTexture evolution of montmorillonite under progressive acid treatment: change from H3 to H2 type of hysteresisLangmuir198735676681
   Web of Science ®Google Scholar
• GuptaHAqilMKharRKAliABhatnagarAMittalGSparfloxacin-loaded PLGA nanoparticles for sustained ocular drug deliveryNanomedicine20106232433319857606
   PubMed Web of Science ®Google Scholar
• HaginoSItagakiHKatoSKobayashiTTanakaMQuantitative evaluation to predict the eye irritancy of chemicals: modification of chorioallantoic membrane test by using trypan blueToxicol In Vitro19915430130420732030
   PubMed Web of Science ®Google Scholar
• QinFZengLZhuYCaoJWangXLiuWPreparation and evaluation of a timolol maleate drug-resin ophthalmic suspension as a sustained-release formulation in vitro and in vivoDrug Dev Ind Pharm201642453554526368660
   PubMed Web of Science ®Google Scholar
• HongSSeongGJHongYJLong-term intraocular pressure fluctuation and progressive visual field deterioration in patients with glaucoma and low intraocular pressures after a triple procedureArch Ophthalmol200712581010101317698746
   PubMedGoogle Scholar
• KonstasAGPMantzirisDACateEAStewartWCEffect of timolol on the diurnal intraocular pressure in exfoliation and primary open-angle glaucomaArch Ophthalmol199711589759799258218
   PubMedGoogle Scholar
• MedeirosFAPinheiroAMouraFCLealBCSusannaRIntraocular pressure fluctuations in medical versus surgically treated glaucomatous patientsJ Ocul Pharmacol Ther200218648949812537675
   PubMed Web of Science ®Google Scholar